Patents by Inventor JAMES CROWE

JAMES CROWE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250281593
    Abstract: The present invention relates to compositions and methods for inducing an adaptive immune response against Hepatitis C virus (HCV) in a subject. In some embodiments, the present invention provides a composition comprising a nucleosidemodified nucleic acid molecule encoding a HCV antigen, adjuvant, or a combination thereof. For example, in some embodiments, the composition comprises a vaccine comprising a nucleoside-modified nucleic acid molecule encoding a HCV antigen, adjuvant, or a combination thereof.
    Type: Application
    Filed: February 14, 2025
    Publication date: September 11, 2025
    Inventors: Drew Weissman, George M. Shaw, Justin R. Bailey, Stuart C. Ray, James Crowe, Andrew Flyak
  • Patent number: 10162166
    Abstract: The present disclosure provides devices, systems and methods for the acquisition and display of captured and/or saved slide images of a sample. In particular embodiments, the images are displayed on a portable computer attached to a removable device configured to hold a slide of the sample. The device is aligned with the portable computer so that the displayed sample image is overlaid with the sample being held by the device. In exemplary embodiments, the displayed image is used as a template for dissection of the sample being held by the device.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: December 25, 2018
    Assignee: MIKROSCAN TECHNOLOGIES, INC.
    Inventors: Victor Casas, James Crowe
  • Publication number: 20160116729
    Abstract: The present disclosure provides devices, systems and methods for the acquisition and display of captured and/or saved slide images of a sample. In particular embodiments, the images are displayed on a portable computer attached to a removable device configured to hold a slide of the sample. The device is aligned with the portable computer so that the displayed sample image is overlaid with the sample being held by the device. In exemplary embodiments, the displayed image is used as a template for dissection of the sample being held by the device.
    Type: Application
    Filed: October 28, 2015
    Publication date: April 28, 2016
    Inventors: Victor CASAS, James CROWE
  • Patent number: 9041242
    Abstract: A method of providing operating electrical power from a stationary power source to a mobile conveyor utilized in material handling at a mine site as the conveyor moves over a predetermined path at the site without having to move long lengths of cable as the conveyor moves away from the power source. The method utilizes a cable reel that features a power receptacle into which a cable connector can be easily plugged and unplugged.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: May 26, 2015
    Assignee: FLSMIDTH A/S
    Inventor: James Crowe
  • Publication number: 20140179154
    Abstract: A method of providing operating electrical power from a stationary power source to a mobile conveyor utilized in material handling at a mine site as the conveyor moves over a predetermined path at the site without having to move long lengths of cable as the conveyor moves away from the power source. The method utilizes a cable reel that features a power receptacle into which a cable connector can be easily plugged and unplugged.
    Type: Application
    Filed: December 26, 2012
    Publication date: June 26, 2014
    Applicant: FLSMIDTH A/S
    Inventor: James Crowe
  • Publication number: 20110135645
    Abstract: The present invention discloses methods for generating antibodies to human metapneumovirus (HMPV) polypeptides, including antibodies that immunospecifically bind to a HMPV F-protein. The invention also discloses methods for preventing, treating, or ameliorating symptoms associated with HMPV infection.
    Type: Application
    Filed: October 4, 2007
    Publication date: June 9, 2011
    Applicant: The Scripps Research Institute
    Inventors: R. Anthony Williamson, Zhifeng Chen, Pietro Paolo Sanna, Dennis R. Burton, James Crowe, John V. Williams
  • Publication number: 20070286873
    Abstract: The present invention provides an improved form of a nucleic acid encoding for the influenza hemagluttinin H5N1. The optimized gene sequence permits production via recombinant means, of the H5N1 HA protein for use in diagnostic assays and vaccines.
    Type: Application
    Filed: May 23, 2007
    Publication date: December 13, 2007
    Inventors: John Williams, James Crowe
  • Publication number: 20070269451
    Abstract: A nucleic acid vaccine construct comprising an isolated polynucleotide which encodes a polypeptide comprising at least five consecutive amino acid residues from the VNTR monomer of Muc1 wherein one or more of said amino acids is a glycosylation site, characterised in that when said isolated polynucleotide is expressed in a mammalian cell, glycosylation of the resulting polypeptide is altered or prevented at at least one of said glycosylation sites.
    Type: Application
    Filed: November 2, 2006
    Publication date: November 22, 2007
    Inventors: James Crowe, Jonathan Ellis
  • Publication number: 20060173765
    Abstract: A method and computer program product are presented for selecting and arranging an appropriate combination of network components, or elements, in a communications network. The selection of network components is done in a manner that maximizes the net present value of cash flow resulting from the provision of communications services between nodes of the network. The method comprises the steps of receiving information that constrains network design and price establishment, and then using the constraint information to select a combination of network components for each link in the communications network. According to the invention, the selection of network components is performed for each of several successive time periods, effectively planning the evolution of the network. The selections are made so that the network components satisfy demand over time while maximizing the net present value of the cash flow that results from the provision of communications services.
    Type: Application
    Filed: March 20, 2006
    Publication date: August 3, 2006
    Inventors: James Crowe, Russell Rushmeier, Indraneel Das, Paul Koster, Jose Alvarez, Mark Reynolds, Lorraine Lotosky
  • Publication number: 20050260216
    Abstract: The present invention relates to an isolated polypeptide useful for immunisation against self-antigens. In particular the invention relates to a self-protein that is capable of raising auto-antibodies when administered in vivo. The invention particularly relates to rendering human cytokines immunogenic in humans. The invention further relates to pharmaceutical compositions comprising such compounds and their use in medicine and to methods for their production.
    Type: Application
    Filed: March 1, 2002
    Publication date: November 24, 2005
    Inventors: Claire Ashman, James Crowe, Jonathan Ellis, Alan Lewis
  • Publication number: 20050186209
    Abstract: The present invention relates to an isolated polypeptide useful for immunisation against self-antigens. In particular the invention relates to a self-protein that is capable of raising auto-antibodies when administered in vivo. The invention particularly relates to rendering human cytokines immunogenic in humans. The invention further relates to pharmaceutical compositions comprising such compounds and their use in medicine and to methods for their production.
    Type: Application
    Filed: January 24, 2005
    Publication date: August 25, 2005
    Inventors: Claire Ashman, James Crowe, Jonathan Ellis, Alan Lewis
  • Publication number: 20050032133
    Abstract: The present invention provides methods for identifying human cancer patients whose cancerous cells overexpress the 17-1A antigen to such an extent as determined herein that the patients may be considered as suitable for treatment with a therapeutic 17-1A antigen binding agent such as an antibody. Preferably the therapeutic antibody is Edrecolomab. Kits for use in such methods and methods of treating patients so identified are also provided.
    Type: Application
    Filed: November 5, 2002
    Publication date: February 10, 2005
    Inventors: PAULA BARRATT, JAMES CROWE, JONATHAN ELLIS, NICHOLAS RAPSON